The Selective in vitro Cytotoxicity of Spirulina-Derived Nanoparticles: A Novel Biomimetic Approach to Cancer Therapy

Cancer treatment often involves significant side effects, necessitating the need for more selective therapies. Spirulina-derived nanoparticles (sNPs) have shown promise as a targeted anticancer strategy.

This study evaluated the cytotoxic effects of sNPs on cancer cell lines TR-146 (buccal), Caco-2 and HT-29 (colorectal), and MCF-7 (breast), compared to the non-cancerous MCF-10A cells. Cytotoxicity was assessed using the XTT assay at concentrations of 25-500 mg/mL over 3-48 hours. Cellular uptake was quantified via fluorescence-activated cell sorting (FACS) and fluorescence microscopy, and endocytic inhibitors were used to investigate the uptake mechanism.

sNPs induced 30-80% mortality in cancer cells, while non-cancerous MCF-10A cells exhibited negligible mortality (<5%). Male-derived Caco-2 cells were more sensitive to sNPs than female-derived HT-29 cells, suggesting potential sex-based differences. FACS analysis showed 100% cellular uptake in all cancer cells, with TR-146 exhibiting the highest fluorescence intensity. Endocytosis inhibition studies revealed that caveolae-mediated endocytosis played a significant role in sNP uptake, particularly in TR-146 and Caco-2 cells.

These findings demonstrate the potential of sNPs as selective and potent anticancer agents, warranting further research to optimize their clinical application.